COVID-19 vaccination information for older people
Following a review of the use of the COVID-19 AstraZeneca vaccine, the Australian Technical Advisory Group on Immunisation (ATAGI) recommends that the COVID-19 vaccine by Pfizer is preferred over the COVID-19 vaccine by AstraZeneca in adults aged under 50 years. Find out more.
Vaccination is the best form of protection against COVID-19 and prevents against severe disease and death. It is a safe and effective way of protecting you and your family.
Both COVID-19 vaccines have been through clinical trials and have been approved by the Therapeutic Goods Administration (TGA) for use in Australia through a rigorous assessment and approval processes, which includes assessment of safety, quality and effectiveness.
The Australian Technical Advisory Group on Immunisation (ATAGI) has advised the AstraZeneca vaccine remains safe and is recommended to be given to people aged 50 years and over.
Adults over 70
Adults over 70 years are being offered the COVID-19 vaccine in Phase 1b of the COVID-19 roll-out in South Australia and can receive their COVID-19 vaccine now.
To book your COVID-19 vaccination appointment visit the Australian Government’s Vaccine Eligibility Checker.
If you have any difficulties making an appointment, ask a trusted person to assist you or call the National COVID-19 Vaccine Information Line on 1800 020 080.
Currently there are a limited number of clinics and vaccines. More appointments will become available as the number of clinics grow and as more vaccine becomes available. Revisit the eligibility checker over the next few weeks if an appointment is not currently available near you.
- Fact sheet - COVID-19 vaccine information for adults over 70
- Frequently asked questions - COVID-19 vaccine FAQ for adults over 70
- COVID-19 vaccines frequently asked questions
Adults over 50
Adults over 50 years will be offered the COVID-19 vaccine in Phase 2a of the COVID-19 roll-out in South Australia.
Information will be provided when the vaccine becomes available to Phase 2a.